HIV Research Preview for IDWeek 2016

Here's a look at some of the noteworthy HIV research being presented at IDWeek 2016 in New Orleans from Oct. 25 to 30. The conference features some of the latest science and research on infectious diseases -- including HIV and hepatitis C.

IDWeek 2016 is the fifth annual combined meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). Here's a sneak peak of some conference highlights to look forward to.

[Editor's Note 10/28/16: This article is being updated with links to our coverage as we post it.]

  • What's Hot in HIV Clinical Research [Link Updated; Read Our Session Recap]
    A staple at IDWeek, as the title suggests, this session will recap what is new in HIV clinical science, as well as HIV epidemiology. It will be presented by Carlos Del Rio, M.D., of Emory University Rollins School of Public Health. Read our summary >>
  • What's Hot in HIV Basic Research [Link Updated; Read Our Session Recap]
    Complementing the previous session, this presentation will review the latest in HIV basic science, pathogenesis and cure research. Irini Sereti, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), will present it. Read our summary >>
  • HIV State of the ART
    Another staple of IDWeek, this session will highlight the latest advances in antiretroviral therapy and what's to come. Of note, Joel Gallant, M.D., M.P.H., will review when and what to start and when to switch. Meanwhile, Ian Frank, M.D., will review what's new and what's next in treatment.
  • HIV Clinical Management
    In this session, researchers will present new findings on different aspects of HIV clinical management. Joseph Eron Jr., M.D., will present a study on retesting suspected low-level HIV viral load blips as a way to prevent extra clinic visits and reduce patient anxiety. Additionally, Gretchen Volpe, M.D., M.P.H., will present a study analyzing the effect of long-term omega-3 fatty acid supplementation on lipids and vascular function among individuals living with HIV.
  • HIV Inflammation and Immune Activation
    This session will address some of the concerns over ongoing inflammation in individuals living with HIV. Of note, one study will examine the relationship between vitamin D metabolites and inflammation in HIV.
  • HIV and Sexually Transmitted Infection Prevention
    Here, we'll see new data on condoms, behavioral research, treatment as prevention and other prevention interventions. One study will highlight the characteristics of individuals who acquire HIV despite regularly accessing health care and testing. Another study will look at the sexual risk behavior and viral suppression of HIV-positive individuals receiving care in New York City.